# A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function

> **NCT07715149** · PHASE1 · RECRUITING · sponsor: **InventisBio Co., Ltd** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Adult Participants
- Hepatic Impairment (HI)

## Interventions

- **DRUG:** D-2570

## Key facts

- **NCT ID:** NCT07715149
- **Lead sponsor:** InventisBio Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-17
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-11-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715149, "A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07715149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*